What To Know
- In conjunction with Pixee's Knee+ platform, the surgeon is able to achieve excellent precision and control, which may result in more efficiency in the operating room and a quicker return to full function for the patient.
- , an orthopedic surgeon at Brigham and Women's Hospital in Boston, MA, using MicroPort Orthopedics Evolution® Medial-Pivot Knee system, designed to deliver a high degree of stability and motion, leading to increased patient satisfaction and survivorship.
MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the successful completion of the first surgery in the U.S. utilizing Pixee Medical, an FDA-cleared augmented reality surgical application for assistance in total knee arthroplasties.
The surgery was performed by Dr. Antonia F. Chen, M.D., M.B.A., an orthopedic surgeon at Brigham and Women’s Hospital in Boston, MA, using MicroPort Orthopedics Evolution® Medial-Pivot Knee system, designed to deliver a high degree of stability and motion, leading to increased patient satisfaction and survivorship. In conjunction with Pixee’s Knee+ platform, the surgeon is able to achieve excellent precision and control, which may result in more efficiency in the operating room and a quicker return to full function for the patient.
Pixee Medical’s Knee+ is a patented platform designed to assist orthopedic surgeons to perform surgeries better and faster by providing real-time positioning of instruments, right in their field of view via smartglasses. Knee+ is intuitive and requires minimal training since it does not change the overall technique for 90 percent of surgeons who use a conventional technique but have never utilized navigation or robots.
“Our mission at MicroPort is to help the patient achieve full function, faster – and this ability to enhance precision and results during surgery will do just that,” said Benny Hagag, President of MicroPort Orthopedics. “The Pixee platform will be transformative in the continued efficiency and precision of our device systems.”
“The first use of Knee+ in Boston is an important step forward as the U.S. represents 50 percent of the worldwide market,” said Sébastien Henry, Founder and CEO of Pixee Medical. “Pixee’s platform is designed to become the cornerstone of data acquisition and exchange during surgery. We look forward to expanding the use of this technology within the US market.”
MicroPort Orthopedics offers various products and techniques to help patients receiving total hip and knee replacements achieve Full Function, Faster. For more information on MicroPort Orthopedics, visit www.microportortho.com.